NPR’s 1A Live Discusses Perinatal Depression and the New Medication Zuranolone
NPR’s 1A Live hosts an episode focusing on perinatal depression, including information on the new medication zuranolone for the treatment of postpartum depression.
NPR’s 1A Live hosts an episode focusing on perinatal depression, including information on the new medication zuranolone for the treatment of postpartum depression.
In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of postpartum depression (PPD). SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors. Since that time, Sage Therapeutics [...]
Postpartum depression (PPD) screening has been increasingly implemented not only in obstetric, but also in primary care and pediatric settings, over the past decade. While there is a growing appreciation for the prevalence of [...]
The following post was first published in OB/GYN News. Please see our OB/GYN News archives here. Publish date: March 3, 2017 Over the last decade, appreciation of the prevalence of perinatal depression – depression during pregnancy and/or [...]